Quintrio
Home

SERVICES-MISC HEALTH & ALLIED SERVICES, NEC

agilon health, inc.

AGL

Agilon Health Inc is a healthcare services company that partners with primary care physicians to support value-based care for senior patients. The company provides a platform that enables physician groups to manage healthcare outcomes and costs through a Medicare-centric, capitated care model and long-term partnerships with community-based physicians.

Last trade $115.93
Day change -$0.82 (-0.70%)
Day range $89.73 – $117.20
Volume 115,754
Market cap $1.96B

Open XNYS

Fundamentals

Key company ratios and reported financial statements.

Source: Massive.com

Key ratios

Valuation

Market capitalization
$1.96B
Price / earnings
—
Price / book
6.98×
Price / sales
0.33×
EV / sales
0.3×
EV / EBITDA
-20.08×

Profitability

Earnings per share
-$5.19
Return on assets
-5.56%
Return on equity
-31.01%
Dividend yield
0%

Liquidity and leverage

Debt / equity
0.11×
Current ratio
1.13×
Quick ratio
1.13×
Cash ratio
0.14×

Cash flow

Price / cash flow
—
Price / free cash flow
—
Free cash flow
-$17.01M

Ratios use trailing-twelve-month financials and market data as of Nov 16, 2026.

Financial statements

Income and cash flow amounts are for the period; balance sheets are point-in-time snapshots. Amounts are shown in USD. Latest 8 quarterly or 5 annual periods are displayed when available.

Income statement for AGL, quarterly periods
Line itemQ3 FY2026 Sep 30, 2026Q2 FY2026 Jun 30, 2026Q1 FY2026 Mar 31, 2026Q4 FY2025 Dec 31, 2025Q3 FY2025 Sep 30, 2025Q2 FY2025 Jun 30, 2025Q1 FY2025 Mar 31, 2025Q4 FY2024 Dec 31, 2024
Revenue$1.52B$1.49B$1.42B$1.57B$1.44B$1.39B$1.53B$1.52B
Cost of revenue$1.42B$1.39B$1.36B$1.66B$1.5B$1.45B$1.48B$1.56B
Gross profit$97.98M$107.14M$65.02M-$90.67M-$67.65M-$52.43M$50.72M-$38.26M
Selling, general and administrative$67.13M$88.51M$54.23M$60.1M$56.2M$56.28M$65.96M$59.76M
Research and development$0$0$0$0$0$0$0$0
Total operating expenses$73.87M$95.37M$61.02M$103.16M$63.63M$63.6M$72.83M$69.85M
Operating income$24.11M$11.77M$4M-$193.83M-$131.27M-$116.03M-$22.11M-$108.1M
Interest expense-$1.74M-$1.61M-$1.81M-$1.72M-$1.84M-$1.57M-$1.52M-$1.57M
Income before taxes$38.91M$17.58M$29.94M-$187.56M-$110.54M-$104.31M-$1.69M-$104.67M
Income taxes$4M-$375K$28K$1.32M-$331K$62K$196K$1.76M
Net income$34.91M$17.96M$48.92M-$188.88M-$110.21M-$104.37M$12.11M-$105.79M
Net income attributable to common shareholders$34.91M$17.96M$48.92M-$188.88M-$110.21M-$104.37M$12.11M-$105.79M
EBITDA$30.85M$18.63M$10.78M-$150.77M-$123.84M-$108.71M-$15.23M-$98.01M
Basic earnings per share$2.08$1.07$2.95-$11.39-$6.65-$6.31$0.73-$6.42
Diluted earnings per share$1.97$1.04$2.94-$11.39-$6.65-$6.31$0.73-$6.42

Recent news

Company coverage with links to the original publishers.

Publication times in UTC
Zacks Investment Research

Agilon Health (AGL) Is Up 2.00% in One Week: What You Should Know

Agilon Health (AGL) has earned a Momentum Style Score of A and a Zacks Rank #1 (Strong Buy) rating. The senior-focused healthcare company has significantly outperformed its industry and the broader market, with shares up 703.33% over the past year compared to the S&P 500's 13.41% gain. Recent earnings estimate revisions have also moved higher, supporting the bullish outlook.

Zacks Investment Research

Best Momentum Stocks to Buy for November 16th

Zacks highlights three stocks with Rank #1 (Strong Buy) ratings and positive momentum characteristics: Agilon Health (healthcare services for seniors) with 84.2% earnings estimate increase, GMR Solutions (emergency medical services) with 13.1% earnings estimate increase, and Parker-Hannifin (motion and control technologies) with 7.1% earnings estimate increase.

Zacks Investment Research

Fast-paced Momentum Stock Agilon (AGL) Is Still Trading at a Bargain

Agilon Health (AGL) is highlighted as a momentum stock trading at a bargain valuation. The senior-focused healthcare company has gained 35.9% over four weeks and 19.8% over 12 weeks, with a high beta of 3.1 indicating significant price volatility. Despite strong momentum metrics and a Zacks Rank #1 (Strong Buy) rating, AGL trades at only 0.32 times sales, suggesting considerable upside potential.

Zacks Investment Research

New Strong Buy Stocks for November 16th

Zacks has added five stocks to its Strong Buy list based on significant increases in consensus earnings estimates over the last 60 days. The selected companies span insurance, emergency medical services, healthcare, power generation, and shipping sectors, with earnings estimate increases ranging from 10.9% to 84.2%.

Zacks Investment Research

Compared to Estimates, Agilon (AGL) Q3 Earnings: A Look at Key Metrics

Agilon Health reported Q3 2026 revenue of $1.52 billion, beating consensus estimates by 4.43%, with EPS of $1.97 versus an estimated -$2.01, representing a significant 198.01% EPS surprise. The company added Medicare Advantage members to 488,000 and saw medical services revenue grow 6% year-over-year. The stock has a Zacks Rank #3 (Hold) rating.

Dividends

Declared distributions and recorded event dates. Forecasts are not shown.

Updated daily

No declared upcoming dividend found.

Ex-dividendAmount / sharePay dateType
Dec 12, 2011$2.4725Dec 16, 2011unknown
Nov 16, 2011$11.25Dec 1, 2011unknown
Aug 17, 2011$11.25Sep 1, 2011unknown
May 11, 2011$11.25Jun 1, 2011unknown
Feb 16, 2011$11.25Mar 1, 2011unknown

Stock splits

Historical share-structure events and their execution dates.

Updated daily
Execution dateSplit ratioEvent type
Mar 31, 20261-for-25reverse split